The Novel Implication of Androgen in Diabetes-induced Alzheimer’s Disease

키워드

참고문헌 (95)

1. Mucke L, "Neurotoxicity of amyloid betaprotein:synaptic and network dysfunction", Cold Spring Harb Perspect Med, 2, pp.a006338~ (2012)
2. Zempel H, "Lost after translation: missorting of Tau protein and consequences for Alzheimer disease", Trends Neurosci, 37, pp.721~732 (2014)
3. Cherry JD, "Neuroinflammation and M2 microglia: the good, the bad, and the inflamed", J Neuroinflammation, 11, pp.98~ (2014)
4. Morris GP, "Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease", Acta Neuropathol Commun, 2, pp.135~ (2014)
5. Huang CC, "Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study", PLoS One, 9, pp.e87095~ (2014)
6. Ohara T, "Glucose tolerance status and risk of dementia in the community: the Hisayama study", Neurology, 77, pp.1126~1134 (2011)
7. Cha DS, "Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer's disease", CNS Neurol Disord Drug Targets, 13, pp.1740~1749 (2014)
8. Crane PK, "Glucose levels and risk of dementia", N Engl J Med, 369, pp.1863~1864 (2013)
9. Kerti L, "Higher glucose levels associated with lower memory and reduced hippocampal microstructure", Neurology, 81, pp.1746~1752 (2013)
10. Matsuzaki T, "Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study", Neurology, 75, pp.764~770 (2010)
11. Hebert LE, "Alzheimer disease in the United States (2010–2050) estimated using the 2010 census", Neurology, 80, pp.1778~1783 (2013)
12. Lin KA, "Marked gender differences in progression of mild cognitive impairment over 8 years", Alzheimers Dement (N Y), 1, pp.103~110 (2015)
13. Barnes LL, "Sex differences in the clinical manifestations of Alzheimer disease pathology", Arch Gen Psychiatry, 62, pp.685~691 (2005)
14. Irvine K, "Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis", J Clin Exp Neuropsychol, 34, pp.989~998 (2012)
15. Rosario ER, "Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease", Neurobiol Aging, 32, pp.604~613 (2011)
16. Gandy S, "Chemical andropause and amyloid-beta peptide", JAMA, 285, pp.2195~2196 (2001)
17. Ramsden M, "Androgens modulate beta-amyloid levels in male rat brain", J Neurochem, 87, pp.1052~1055 (2003)
18. George S, "Nonsteroidal selective androgen receptor modulators and selective estrogen receptor beta agonists moderate cognitive deficits and amyloid-beta levels in a mouse model of Alzheimer's disease", ACS Chem Neurosci, 4, pp.1537~1548 (2013)
19. Watanabe T, "Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia", Metabolism, 53, pp.476~482 (2004)
20. Chu LW, "Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men", Clin Endocrinol (Oxf), 68, pp.589~598 (2008)
21. Rubinow DR, "Androgens, brain, and behavior", Am J Psychiatry, 153, pp.974~984 (1996)
22. Simerly RB, "Distribution of androgen and estrogen receptor mRNAcontaining cells in the rat brain: an in situ hybridization study", J Comp Neurol, 294, pp.76~95 (1990)
23. Yu WH, "Androgen receptors in cranial nerve motor nuclei of male and female rats", J Neurobiol, 46, pp.1~10 (2001)
24. Bezdickova M, "Distribution of nuclear receptors for steroid hormones in the human brain: a preliminary study", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 151, pp.69~71 (2007)
25. Zheng P, "Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance", Prog Neurobiol, 89, pp.134~152 (2009)
26. Melcangi RC, "Neurosteroids: measurement and pathophysiologic relevance", Neurochem Int, 52, pp.503~505 (2008)
27. Frye CA, "The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents", Brain Res Brain Res Rev, 37, pp.201~222 (2001)
28. Darnaudéry M, "The neurosteroid pregnenolone sulfate infused into the medial septum nucleus increases hippocampal acetylcholine and spatial memory in rats", Brain Res, 951, pp.237~242 (2002)
29. Yaffe K, "Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women", J Nutr Health Aging, 10, pp.293~295 (2006)
30. Stolk RP, "Insulin and cognitive function in an elderly population. The Rotterdam Study", Diabetes Care, 20, pp.792~795 (1997)
31. Xia W, "Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study", Psychoneuroendocrinology, 38, pp.2493~2501 (2013)
32. Moran C, "Brain atrophy in type 2 diabetes: regional distribution and influence on cognition", Diabetes Care, 36, pp.4036~4042 (2013)
33. Brands AM, "Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes", Diabetes, 55, pp.1800~1806 (2006)
34. Jung HJ, "Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62", Exp Neurol, 248, pp.441~450 (2013)
35. Planel E, "Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms", J Neurosci, 27, pp.13635~13648 (2007)
36. Ho L, "Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease", FASEB J, 18, pp.902~904 (2004)
37. Cao D, "Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease", J Biol Chem, 282, pp.36275~36282 (2007)
38. Schulingkamp RJ, "Insulin receptors and insulin action in the brain: review and clinical implications", Neurosci Biobehav Rev, 24, pp.855~872 (2000)
39. Steen E, "Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?", J Alzheimers Dis, 7, pp.63~80 (2005)
40. Zhao L, "Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade:implications for Alzheimer's disease intervention", J Neurosci, 24, pp.11120~11126 (2004)
41. Luchsinger JA, "Improved diabetes control in the elderly delays global cognitive decline", J Nutr Health Aging, 15, pp.445~449 (2011)
42. Chen Y, "Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via upregulating BACE1 transcription", Proc Natl Acad Sci U S A, 106, pp.3907~3912 (2009)
43. Craft S, "Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial", Arch Neurol, 69, pp.29~38 (2012)
44. Searcy JL, "Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease", J Alzheimers Dis, 30, pp.943~961 (2012)
45. Barron AM, "Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease", PLoS One, 8, pp.e78554~ (2013)
46. Freude S, "Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease", FASEB J, 23, pp.3315~3324 (2009)
47. Killick R, "Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice", Biochem Biophys Res Commun, 386, pp.257~262 (2009)
48. Yu IC, "Androgen receptor roles in insulin resistance and obesity in males:the linkage of androgen-deprivation therapy to metabolic syndrome", Diabetes, 63, pp.3180~3188 (2014)
49. English KM, "Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms", Eur Heart J, 21, pp.890~894 (2000)
50. Moffat SD, "Effects of testosterone on cognitive and brain aging in elderly men", Ann N Y Acad Sci, 1055, pp.80~92 (2005)
51. Rosario ER, "Age-related testosterone depletion and the development of Alzheimer disease", JAMA, 292, pp.1431~1432 (2004)
52. Hogervorst E, "Serum total testosterone is lower in men with Alzheimer's disease", Neuroendocrinol Lett, 22, pp.163~168 (2001)
53. Rosario ER, "Androgen regulation of betaamyloid protein and the risk of Alzheimer's disease", Brain Res Brain Res Rev, 57, pp.444~453 (2008)
54. Gooren LJ, "Androgens and male behavior", Mol Cell Endocrinol, 198, pp.31~40 (2002)
55. Morley JE, "Androgens and aging", Maturitas, 38, pp.61~71 (2001)
56. Hogervorst E, "Low free testosterone is an independent risk factor for Alzheimer's disease", Exp Gerontol, 39, pp.1633~1639 (2004)
57. Rasmuson S, "Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease", Dement Geriatr Cogn Disord, 13, pp.74~79 (2002)
58. Grossmann M, "Low testosterone levels are common and associated with insulin resistance in men with diabetes", J Clin Endocrinol Metab, 93, pp.1834~1840 (2008)
59. Kapoor D, "Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity", Diabetes Care, 30, pp.911~917 (2007)
60. Kapoor D, "The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes", Eur J Endocrinol, 156, pp.595~602 (2007)
61. Bhasin S, "Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity", J Clin Endocrinol Metab, 92, pp.1049~1057 (2007)
62. Haidar A, "Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes", Aging Male, 10, pp.189~196 (2007)
63. Hardy J, "The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics", Science, 297, pp.353~356 (2002)
64. Gouras GK, "Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides", Proc Natl Acad Sci U S A, 97, pp.1202~1205 (2000)
65. Rosario ER, "Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease", J Neurosci, 26, pp.13384~13389 (2006)
66. Iwata N, "Metabolism of amyloidbeta peptide and Alzheimer's disease", Pharmacol Ther, 108, pp.129~148 (2005)
67. Lund TD, "Pre- or postnatal testosterone and flutamide effects on sexually dimorphic nuclei of the rat hypothalamus", Brain Res Dev Brain Res, 120, pp.261~266 (2000)
68. Yang SL, "Perinatal androgenization prevents age-related neuron loss in the sexually dimorphic nucleus of the preoptic area in female rats", Dev Neurosci, 26, pp.54~60 (2004)
69. Tetzlaff JE, "Motoneuron injury and repair: new perspectives on gonadal steroids as neurotherapeutics", J Mol Neurosci, 28, pp.53~64 (2006)
70. Ramsden M, "Androgens modulate neuronal vulnerability to kainate lesion", Neuroscience, 122, pp.573~578 (2003)
71. Ahlbom E, "Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism", Brain Res, 892, pp.255~262 (2001)
72. Nguyen TV, "Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection", J Neurochem, 94, pp.1639~1651 (2005)
73. Park SY, "Caspase-3-and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta amyloid-treated hippocampal neurons", Neuroscience, 144, pp.119~127 (2007)
74. Gatson JW, "Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase", Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells, 2006, pp.147, 2028~2034
75. Gatson JW, "Activation of a membraneassociated androgen receptor promotes cell death in primary cortical astrocytes", Endocrinology, 148, pp.2458~2464 (2007)
76. Fix C, "Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells", Proc Natl Acad Sci U S A, 101, pp.10919~10924 (2004)
77. Unni E, "Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence", Cancer Res, 64, pp.7156~7168 (2004)
78. Hammond J, "Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons", J Neurochem, 77, pp.1319~1326 (2001)
79. Pike CJ, "Protective actions of sex steroid hormones in Alzheimer's disease", Front Neuroendocrinol, 30, pp.239~258 (2009)
80. Simon D, "Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study", Diabetologia, 35, pp.173~177 (1992)
81. Kupelian V, "Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups", J Clin Endocrinol Metab, 93, pp.3403~3410 (2008)
82. Yialamas MA, "Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism", J Clin Endocrinol Metab, 92, pp.4254~4259 (2007)
83. Stanworth RD, "Testosterone in obesity, metabolic syndrome and type 2 diabetes", Front Horm Res, 37, pp.74~90 (2009)
84. Liu L, "A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment", Neurobiol Dis, 31, pp.46~57 (2008)
85. Jia J, "Amelioratory effects of testosterone treatment on cognitive performance deficits induced by soluble Abeta1-42 oligomers injected into the hippocampus", Horm Behav, 64, pp.477~486 (2013)
86. Jia JX, "Effects of testosterone on synaptic plasticity mediated by androgen receptors in male SAMP8 mice", J Toxicol Environ Health A, 79, pp.849~855 (2016)
87. MK801 binding in the hippocampus of male rats, "Brain Res", 1995, 270~274
88. Pouliot WA, "Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1hippocampal pyramidal cells", Synapse, 23, pp.10~19 (1996)
89. Li S, "Effects of dihydrotestosterone on synaptic plasticity of hippocampus in male SAMP8 mice", Exp Gerontol, 48, pp.778~785 (2013)
90. Frye CA, "5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats", Psychoneuroendocrinology, 29, pp.1019~1027 (2004)
91. Leranth C, "Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats", J Neurosci, 24, pp.495~499 (2004)
92. Giagulli VA, "Serum testosterone and cognitive function in ageing male: updating the evidence", Recent Pat Endocr Metab Immune Drug Discov, 10, pp.22~30 (2016)
93. Almeida OP, "One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men", Psychoneuroendocrinology, 29, pp.1071~1081 (2004)
94. Bussiere JR, "Androgen deprivation impairs memory in older men", Behav Neurosci, 119, pp.1429~1437 (2005)
95. Moffat SD, "Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men", J Clin Endocrinol Metab, 87, pp.5001~5007 (2002)

관련 논문AI추천